Phase I study of non-replicating autologous tumor cell injections using cells prepared with or without GM-CSF gene transduction in patients with metastatic renal cell carcinoma

Hum Gene Ther. 1995 Mar;6(3):347-68. doi: 10.1089/hum.1995.6.3-347.

Authors

A J Berns¹, S Clift, L K Cohen, R C Donehower, G Dranoff, K M Hauda, E M Jaffee, A J Lazenby, H I Levitsky, F F Marshall, et al.

Affiliation

¹ Somatix Therapy Corporation, Alameda, CA 94501, USA.

PMID: 7779918
DOI: 10.1089/hum.1995.6.3-347

No abstract available

MeSH terms

Animals
Carcinoma, Renal Cell / pathology
Carcinoma, Renal Cell / secondary*
Carcinoma, Renal Cell / therapy*
Cell Transplantation*
Clinical Protocols
Clinical Trials, Phase I as Topic
Genetic Therapy
Granulocyte-Macrophage Colony-Stimulating Factor / genetics*
Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology
Humans
Immunotherapy
Mice
Transduction, Genetic
Transplantation, Autologous
Tumor Cells, Cultured

Substances

Granulocyte-Macrophage Colony-Stimulating Factor